Publications by authors named "M-P Sablin"

Claim this Profile
P
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer.
Alexandra Leary, Christophe Le Tourneau, Andrea Varga, Marie-Paule Sablin, Carlos Gomez-Roca

Invest New Drugsยท August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis